1. Home
  2. SCNI vs ARTL Comparison

SCNI vs ARTL Comparison

Compare SCNI & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scinai Immunotherapeutics Ltd.

SCNI

Scinai Immunotherapeutics Ltd.

N/A

Current Price

$1.55

Market Cap

1.2M

Sector

Health Care

ML Signal

N/A

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$1.45

Market Cap

1.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCNI
ARTL
Founded
2003
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2M
1.4M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
SCNI
ARTL
Price
$1.55
$1.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 103.0K
27.2K
Earning Date
08-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 50.00
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.52
52 Week High
$3.58
$179.19

Technical Indicators

Market Signals
Indicator
SCNI
ARTL
Relative Strength Index (RSI) 77.95 26.43
Support Level $1.43 $0.52
Resistance Level $1.76 $6.81
Average True Range (ATR) 0.08 0.25
MACD 0.10 0.00
Stochastic Oscillator 93.78 0.00

Price Performance

Historical Comparison
SCNI
ARTL

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: